HIV-2 (NIH-Z Strain) Purified Virus
Catalog #: 10-127-000
Size: 1.0 mg
Biological Substance A
Human Immunodeficiency Virus type 2 (NIH-Z Strain) propagated in HuT 78 cells and purified from culture supernatant and cells showing cytopathic effect.
For research use only.
APPLICATION FOR USE
- In vitro Infectivity Assay
- Antiviral Studies
- Spiking Studies
- Virus Neutralization Assay
- Virus Ultrastructural Studies
- Nucleic Acid-Based Assay
QUALITY CONTROL TESTING INCLUDES
- Sterility
- TCID50
- Protein Concentration
- Virus Particle Count
SHIPPING AND STORAGE:
This product is shipped frozen on dry ice. Store at -70°C upon receipt. Avoid multiple freeze-thaw cycles as product degradation may result.
RECOMMENDATIONS:
Upon thawing, centrifuge the vial for a few seconds to remove residual droplets from the lid.
SAFE HANDLING RECOMMENDATIONS:
This preparation of HIV is a BIOHAZARDOUS material containing ACTIVE VIRUS and should be handled in accordance with biosafety guidelines defined in the BMBL, NIH-CDC HHS Publication No. (CDC) 21-1112.
REFERENCE ARTICLES
Palm, A., Lemey, P., Jansson, M., Månsson, F., Kvist, A., Szojka, Z., Biague, A., da Silva, Z., Rowland-Jones, S., and Norrgren, H. et al. (2019). Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection. mBio 10, e01245-18. https://doi.org/10.1128/mbio.01245-18
Trevino, A., Soriano, V., Poveda, E., Parra, P., Cabezas, T., Caballero, E., Roc, L., Rodriguez, C., Eiros, J., and Lopez, M. et al. (2014). HIV-2 viral tropism influences CD4+ T cell count regardless of viral load. Journal Of Antimicrobial Chemotherapy 69, 2191-2194. https://doi.org/10.1093/jac/dku119
Damond, F., Benard, A., Balotta, C., Boni, J., Cotten, M., Duque, V., Ferns, B., Garson, J., Gomes, P., and Goncalves, F. et al. (2011). An International Collaboration To Standardize HIV-2 Viral Load Assays: Results from the 2009 ACHIEV2E Quality Control Study. Journal Of Clinical Microbiology 49, 3491-3497. https://doi.org/10.1128/jcm.02389-10
- New Product
- Available as Custom Product-Discontinued
- Limited Quantities Remaining-Discontinued
- Call For Availability
- Biohazard Category A
- Biohazard Category B
-
10-254-000Vaccinia (WR Strain) Purified Virus1.0 mg
-
10-252-000Vaccinia (Lister Strain) Purified Virus1.0 mg
-
10-223-100SRV-5 Purified Virus100 µg
-
10-223-000SRV-5 Purified Virus1.0 mg
-
10-218-000SRV-2 Purified Virus1.0 mg
-
10-152-000SRV-1 (Macaque Strain) Purified Virus1.0 mg
-
10-152-100SRV-1 (Macaque Strain) Purified Virus100 µg
-
10-149-000SIV (mac251 Strain) Purified Virus1.0 mg
-
10-149-100SIV (mac251 Strain) Purified Virus100 µg
-
10-247-000RSV-A (A2 Strain) Purified Virus1.0 mg
-
10-247-100RSV-A (A2 Strain) Purified Virus100 µg
-
10-288-000PCV2b Purified Virus1.0 mL
-
10-220-500Human Influenza B/Lee/40 Purified Virus0.5 mg
-
10-210-500Human Influenza A/PR/8/34 (H1N1) Purified Virus0.5 mg
-
10-287-500Human Influenza A/New Caledonia/20/99 (H1N1) Purified Virus0.5 mg
-
10-281-500Human Influenza A/Mexico/4108/2009 (H1N1) Purified Virus (Swine-Origin)0.5 mg
-
10-201-500Human Influenza A/Hong Kong/8/68 (H3N2) Purified Virus0.5 mg
-
10-280-500Human Influenza A/California/4/2009 (H1N1) Purified Virus (Swine-Origin)0.5 mg
-
10-259-000Human Influenza A/2/Japan/305/57 (H2N2) Purified Virus1.0 mg
-
10-112-000HTLV-I (MT-2 Strain) Purified Virus1.0 mg
-
10-112-100HTLV-I (MT-2 Strain) Purified Virus100 µg
-
10-110-000HSV-1 (MacIntyre Strain) Purified Virus1.0 mg
-
10-118-000HIV-1 (IIIB Strain) Purified Virus1.0 mg
-
10-118-100HIV-1 (IIIB Strain) Purified Virus100 µg
-
10-250-000FeLV (Thielen Strain) Purified Virus1.0 mg
-
10-115-000EBV (B95-8 Strain) Purified Virus1.0 mg
-
10-115-100EBV (B95-8 Strain) Purified Virus100 µg
-
10-198-000Human Adenovirus-5 Purified Virus1.0 mL
